These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15334444)

  • 1. Treatment with statins does not exhibit a clinically relevant corticosteroid-sparing effect in patients with giant cell arteritis.
    García-Martínez A; Hernández-Rodríguez J; Grau JM; Cid MC
    Arthritis Rheum; 2004 Aug; 51(4):674-8. PubMed ID: 15334444
    [No Abstract]   [Full Text] [Related]  

  • 2. Statin therapy does not seem to benefit giant cell arteritis.
    Narváez J; Bernad B; Nolla JM; Valverde J
    Semin Arthritis Rheum; 2007 Apr; 36(5):322-7. PubMed ID: 17204308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Corticosteroid saving-up in giant cell arteritis?].
    Schnabel A
    Dtsch Med Wochenschr; 2002 Sep; 127(37):1910. PubMed ID: 12226792
    [No Abstract]   [Full Text] [Related]  

  • 4. Giant cell arteritis in Mumbai.
    Singh S; Balakrishnan C; Mangat G; Samant R; Bambani M; Kalke S; Joshi VR
    J Assoc Physicians India; 2010 Jun; 58():372-4. PubMed ID: 21125778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Polymyalgia rheumatica and giant-cell arteritis].
    Glazunov AV; Zhiliaev EV; Toldieva FA; Dzhanashiia PKh
    Klin Med (Mosk); 2005; 83(11):39-45. PubMed ID: 16404938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin or nonsteroidal anti-inflammatory drug use is associated with lower erythrocyte sedimentation rate in patients with giant cell arteritis.
    Hegg R; Lee AG; Tagg NT; Zimmerman MB
    J Neuroophthalmol; 2011 Jun; 31(2):135-8. PubMed ID: 21358421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of treatment after eye involvement in giant cell arteritis.
    Arashvand K; Alexander WL; Dasgupta B
    J Rheumatol; 2007 Sep; 34(9):1945. PubMed ID: 17787057
    [No Abstract]   [Full Text] [Related]  

  • 8. Scalp necrosis in giant cell arteritis after initiation of therapeutic corticosteroids.
    Brick KE; Cook-Norris RH; Wetter DA; Warrington KJ
    J Am Acad Dermatol; 2010 Aug; 63(2):343-4. PubMed ID: 20633804
    [No Abstract]   [Full Text] [Related]  

  • 9. [Functional diagnosis in follow-up of temporal arteritis treatment].
    Ulrich C; Ulrich WD; Ulrich D
    Fortschr Ophthalmol; 1990; 87(6):667-70. PubMed ID: 2086416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving therapeutic options for patients with giant cell arteritis.
    Pipitone N; Salvarani C
    Curr Opin Rheumatol; 2008 Jan; 20(1):17-22. PubMed ID: 18281852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
    Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
    Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Etiology and treatment of temporal arteritis].
    Gembitskiĭ EV; Glazunov AV; Zhiliaev EV; Prekhorova EG
    Klin Med (Mosk); 1994; 72(6):18-21. PubMed ID: 7898001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis.
    Wilson JC; Sarsour K; Collinson N; Tuckwell K; Musselman D; Klearman M; Napalkov P; Jick SS; Stone JH; Meier CR
    Semin Arthritis Rheum; 2017 Jun; 46(6):819-827. PubMed ID: 28040244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Iatrogenic central serous chorioretinopathy during glucocorticoid therapy for temporal arteritis].
    Steichen O; Chauveheid MP; Lidove O; Doan S; Papo T
    Rev Med Interne; 2006 Sep; 27(9):702-5. PubMed ID: 16854504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects.
    Martínez-Taboada VM; Rodríguez-Valverde V; Carreño L; López-Longo J; Figueroa M; Belzunegui J; Mola EM; Bonilla G
    Ann Rheum Dis; 2008 May; 67(5):625-30. PubMed ID: 18086726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mural inflammatory hyperenhancement in MRI of giant cell (temporal) arteritis resolves under corticosteroid treatment.
    Bley TA; Markl M; Schelp M; Uhl M; Frydrychowicz A; Vaith P; Peter HH; Langer M; Warnatz K
    Rheumatology (Oxford); 2008 Jan; 47(1):65-7. PubMed ID: 18077491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment on: statin therapy does not seem to benefit giant cell arteritis.
    Pieringer H; Biesenbach G
    Semin Arthritis Rheum; 2008 Aug; 38(1):63-4; 64-5. PubMed ID: 17889259
    [No Abstract]   [Full Text] [Related]  

  • 18. A 26-week feasibility study comparing the efficacy and safety of modified-release prednisone with immediate-release prednisolone in newly diagnosed cases of giant cell arteritis.
    Raine C; Stapleton PP; Merinopoulos D; Maw WW; Achilleos K; Gayford D; Mapplebeck S; Mackerness C; Schofield P; Dasgupta B
    Int J Rheum Dis; 2018 Jan; 21(1):285-291. PubMed ID: 28791802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of the effect of statin use on the efficacy of bacillus calmette-guerin treatment for transitional cell carcinoma of the bladder.
    Berglund RK; Savage CJ; Vora KC; Kurta JM; Cronin AM
    J Urol; 2008 Oct; 180(4):1297-300; discussion 1300. PubMed ID: 18707737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High blood levels of chromogranin A in giant cell arteritis identify patients refractory to corticosteroid treatment.
    Di Comite G; Previtali P; Rossi CM; Dell'Antonio G; Rovere-Querini P; Praderio L; Dagna L; Corti A; Doglioni C; Maseri A; Sabbadini MG; Manfredi AA
    Ann Rheum Dis; 2009 Feb; 68(2):293-5. PubMed ID: 19139212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.